Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • wjeck
    Member
    • Mar 2009
    • 39

    #1

    Hi from Chapel Hill, NC

    Hi everyone,

    I'm new to the forum today and I love what I see. I've been in next gen sequencing for about two years. I worked on VCAKE, and it's still alive and kicking, now optimized for 454/Illumina bacterial genome assembly ... pipeline forthcoming at vcake.sourceforge.net hopefully in the next few weeks. I can't claim it as my work, but I might as well pump it up a little.

    Now I'm an MD/PhD student looking to apply the new genomics to clinical questions (particularly oncology). I've just spent 2 years in medical school so I am all but completely out of the loop, but I'm looking forward to getting back up to speed.

    --Will Jeck
    UNC Chapel Hill
    School of Medicine
  • yoyoq
    Junior Member
    • Jul 2009
    • 9

    #2
    hi,
    i have some vcake questions.
    does vcake consider both strands of the input sequence?

    i have short reads(31 long) , in my test case they all blat perfectly
    to a known genome and there seems to be decent overlap.
    but the vcake is not tying the contigs together, i am getting a
    max contig of 100 for a 1000 base region
    do you have any suggstions?

    thanks
    jpd

    Comment

    • wjeck
      Member
      • Mar 2009
      • 39

      #3
      The short answer is yes, it does consider both strands.

      My recommendation would generally be not to use VCAKE unless you are doing hybrid assemblies of 454 and Illumina data. VCAKE has not been maintained to deal with updates in the technologies, unlike some other algorithms. I would refer to this thread and try algorithms like Velvet, which make use of a more sophisticated graph decomposition method.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      20 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      43 views
      0 reactions
      Last Post SEQadmin2  
      Working...